While MTA1 is a “new” molecule in canine UC, the inducible COX2 inflammatory and oncogenic pathway that participates in cancer cell proliferation, migration, survival, stimulation of angiogenesis and promotion of drug resistance has already been recognized in canine and human invasive UC (57, 58). The gene discussed is PTGS2; the disease is cancer.